Tamoxifen
Indication
For treating premenopausal women at high risk of breast cancer unless they have a past history or may be at increased risk of thromboembolic disease or endometrial cancer.
Amber level 0
Brand:
Nice TA:
Commissioning responsibility:
CCG (HRG included)
PbR excluded:
No
BNF chapter:
Endocrine system
Background
See NICE CG164 https://www.nice.org.uk/guidance/cg164
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: